![](/img/cover-not-exists.png)
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy
Navid, Fariba, Santana, Victor M., Neel, Michael, McCarville, M. Beth, Shulkin, Barry L., Wu, Jianrong, Billups, Catherine A., Mao, Shenghua, Daryani, Vinay M., Stewart, Clinton F., Kunkel, Michelle,Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.30841
Date:
July, 2017
File:
PDF, 961 KB
english, 2017